lifestyle.capitolhilltimes.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • Beach Cities Commercial Bank Announces Fourth Quarter 2025 Financial Results

    Beach Cities Commercial Bank Announces Fourth Quarter 2025 Financial Results

    Business Wire
    February 12, 2026
  • Obsidian Solutions Group Secures Contract for U.S. Marine Corps Vehicle Training Support

    Obsidian Solutions Group Secures Contract for U.S. Marine Corps Vehicle Training Support

    Business Wire
    February 12, 2026
  • Copart, Inc. to Release Second Quarter Fiscal 2026 Results

    Copart, Inc. to Release Second Quarter Fiscal 2026 Results

    Business Wire
    February 12, 2026
  • Leading the Industry: Top Coal Shearer Gears Manufacturers Revolutionizing Mining Efficiency

    Leading the Industry: Top Coal Shearer Gears Manufacturers Revolutionizing Mining Efficiency

    EIN Newswire
    February 12, 2026
  • Mind the Gap Business Book to Be Published by Wiley

    Mind the Gap Business Book to Be Published by Wiley

    EIN Newswire
    February 12, 2026
  • RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

    RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

    THE ROSEN LAW FIRM, P. A.
    February 12, 2026
  • Rebecca Zung Launches Groundbreaking Legal Leverage AI Platform

    Rebecca Zung Launches Groundbreaking Legal Leverage AI Platform

    PR Underground
    February 12, 2026
  • Are DVN, STEL, CLBK, NFBK Obtaining Fair Deals for their Shareholders?

    Are DVN, STEL, CLBK, NFBK Obtaining Fair Deals for their Shareholders?

    Halper Sadeh LLC
    February 12, 2026
  • Icahn Enterprises L.P. Announces Q4 2025 Earnings Conference Call

    Icahn Enterprises L.P. Announces Q4 2025 Earnings Conference Call

    ICAHN ENTERPRISES L.P.
    February 12, 2026
  • Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

    Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

    Business Wire
    February 12, 2026
Prev
1 … 10,087 10,088 10,089 10,090 10,091 … 31,659
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.